The COVID-19 pandemic may well have ushered in the age of decentralized clinical trials (DCTs), but the clinical research enterprise is far from being fully prepared to maximize their potential […]
Thought leaders from across the clinical research spectrum came together last week to share insights, predictions, and best practices regarding leadership and other important topics during the latest round of […]
We applaud the Sept. 2 op-ed by Rep. Karen Bass (D-Calif.) regarding the importance of promoting diversity in the clinical trial patient population [“Vaccine trials’ lack of diversity threatens their […]
“After you’ve been a clinical research associate (CRA), the sky’s the limit,” says Reginald Hooks, MS, MPH, PMP, associate director of clinical operations for Oncolytics Biotech. “You understand the whole […]
The clinical trial industry continues to grapple with finding new and more effective ways to expand its efforts to combat Alzheimer’s. The obstacles are real. Alzheimer’s trials cost more per […]